Macrophage
Showing 1 - 25 of 1,807
Macrophage PET/CT Imaging Using 64Cu-DOTATATE for Diagnosis of
Recruiting
- Cardiac Sarcoidosis
- 64Cu-DOTATATE PET/CT scan
-
Copenhagen, DenmarkRigshospitalet
Nov 14, 2023
RT201(Tumor Antigen-specific Macrophage Tumor Vaccine)
Recruiting
- Cervical
-
Wuxi, Jiangsu, ChinaWuxi People's Hospital
Jul 3, 2023
EVALUATION OF MACROPHAGE INFLAMMATORY PROTEIN-1a AS A
Not yet recruiting
- Periodontitis Chronic Generalized Severe
- +2 more
-
Rohtak, Haryana, IndiaPost Graduate Institute of Dental Sciences
Aug 23, 2023
SARS-CoV-2 Pneumonia Trial in Durham (Ozone)
Not yet recruiting
- SARS-CoV-2 Pneumonia
-
Durham, North CarolinaDuke University Medical Center
Mar 3, 2023
Dietary Protein Trial in Saint Louis (Dietary protein shake)
Active, not recruiting
- Dietary Protein
- Dietary protein shake
-
Saint Louis, MissouriWashington University
Jan 29, 2023
Acute Respiratory Distress Syndrome, Ventilator Associated Pneumonia Trial in Denver (Non-Bronchoscopic Mini Bronchoalveolar
Recruiting
- Acute Respiratory Distress Syndrome
- Ventilator Associated Pneumonia
- Non-Bronchoscopic Mini Bronchoalveolar Lavage
-
Denver, ColoradoIntermountain Health - St. Joseph's Hospital - National Jewish H
Mar 2, 2023
Macrophage Activation Syndrome Trial (Ruxolitinib, methylprednisolone)
Not yet recruiting
- Macrophage Activation Syndrome
- (no location specified)
Mar 16, 2022
Breast Cancer Trial in Toulouse (Patients with breast cancer (stage I, II III or IV))
Completed
- Breast Cancer
- Patients with breast cancer (stage I, II III or IV)
-
Toulouse, FranceInstitut Universitaire du Cancer de Toulouse - Oncopole
Sep 27, 2022
Macrophage Function
Enrolling by invitation
- Polymorphism
- Lung Inflammation
-
Research Triangle Park, North CarolinaNIEHS, Research Triangle Park
Jul 6, 2022
Leiomyosarcoma Trial in Toulouse (Blood samples will be collected at different times.)
Not yet recruiting
- Leiomyosarcoma
- Blood samples will be collected at different times.
-
Toulouse, FranceInstitut Universitaire du Cancer Toulouse - Oncopole
Aug 2, 2022
Air Pollution Trial in Piscataway (Clean Air, Ozone)
Recruiting
- Air Pollution
- Clean Air
- Ozone
-
Piscataway, New JerseyRutgers - EOHSI
Mar 20, 2023
Toxicities in Children and Adults With Cancer
Active, not recruiting
- Macrophage Activation Syndrome
- Primary Hemophagocytic Lymphohistiocytosis
-
Bethesda, MarylandNational Cancer Institute (NCI)
Sep 17, 2022
ARDS Trial in Nanjing
Recruiting
- ARDS
-
Nanjing, Jiangsu, ChinaNanjing Zhong-Da Hospital, Southeast University
Jul 17, 2022
Macrophage Activation Syndrome Trial in Birmingham (kineret, )
Active, not recruiting
- Macrophage Activation Syndrome
- kineret
- placebo
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Dec 13, 2021
Neuroblastoma Trial in Guangzhou (Naxitamab monotherapy, GM-CSF, Irinotecan)
Recruiting
- Neuroblastoma
- Naxitamab monotherapy
- +6 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Aug 31, 2023
DIABETES, MYOCARD INFARCTUS Trial in Nice (blood sample)
Completed
- DIABETES
- MYOCARD INFARCTUS
- blood sample
-
Nice, FranceCHU de Nice
May 13, 2022
Diabetes, Gastroparesis With Diabetes Trial in Rochester (PET/CT Scan with 11C-ER176, Core biopsy of gastric muscle)
Active, not recruiting
- Diabetes
- Gastroparesis With Diabetes Mellitus
- PET/CT Scan with 11C-ER176
- Core biopsy of gastric muscle
-
Rochester, MinnesotaMayo Clinic in Rochester
Apr 11, 2022
Neuroblastoma Recurrent Trial in Hong Kong (Natural killer cell, Dinutuximab beta, Interleukin-2)
Recruiting
- Neuroblastoma Recurrent
- Natural killer cell
- +4 more
-
Hong Kong, Hong KongHong Kong Children's Hospital
Feb 22, 2023
Macrophage-mediated Inflammation in White Adipose Tissue and
Suspended
- Non-Alcoholic Fatty Liver Disease
-
London, United KingdomImperial College NHS Trust
Mar 24, 2022
Macrophage Activation Syndrome, Lymphohistiocytosis, Hemophagocytic, Arthritis, Juvenile Trial in Worldwide (Emapalumab)
Completed
- Macrophage Activation Syndrome
- +3 more
-
Cincinnati, Ohio
- +4 more
May 16, 2022
Recurrent Osteosarcoma Trial in Los Angeles, New York, Houston (humanized anti-GD2 antibody, GM-CSF)
Recruiting
- Recurrent Osteosarcoma
- humanized anti-GD2 antibody
- GM-CSF
-
Los Angeles, California
- +2 more
Dec 22, 2022
Systemic Lupus Erythematosus Trial (Macrophage migration inhibitory factor)
Not yet recruiting
- Systemic Lupus Erythematosus
- Macrophage migration inhibitory factor
- (no location specified)
Feb 13, 2022
Neuroblastoma Trial in New York (Hu3F8 With GM-CSF)
Active, not recruiting
- Neuroblastoma
- Hu3F8 With GM-CSF
-
New York, New YorkMemorial Sloan Kettering Cancer Center
May 2, 2022